CO6341568A2 - Composicion inmunologica - Google Patents

Composicion inmunologica

Info

Publication number
CO6341568A2
CO6341568A2 CO11022016A CO11022016A CO6341568A2 CO 6341568 A2 CO6341568 A2 CO 6341568A2 CO 11022016 A CO11022016 A CO 11022016A CO 11022016 A CO11022016 A CO 11022016A CO 6341568 A2 CO6341568 A2 CO 6341568A2
Authority
CO
Colombia
Prior art keywords
antigen
compositions
immunological
virus
immune response
Prior art date
Application number
CO11022016A
Other languages
English (en)
Inventor
Philip Ralph Lehrbach
William John Cheshire
Zhixian Xin
Original Assignee
Five Giralda Farms
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904261A external-priority patent/AU2008904261A0/en
Application filed by Five Giralda Farms filed Critical Five Giralda Farms
Publication of CO6341568A2 publication Critical patent/CO6341568A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones inmunológicas que comprenden sulfolipo-ciclodextrina (SL-CD) y saponina o Quil A y opcionalmente al menos un antígeno. La invención se refiere a procedimientos y composiciones inmunológicas que comprenden al menos un antígeno, que puede ser un antígeno veterinario. El antígeno veterinario en los procedimientos y composiciones inmunológicas de a invención puede ser un antígeno bovino. La invención se refiere a procedimientos y composiciones inmunológicas que comprenden virus de la fiebre efímera bovina (VFEB), herpes virus bovino 1 (RBI) o virus de la lengua azul (VLA). La invención comprende procedimientos para provocar una respuesta inmune frente a VFEB, RBI o VLA en un animal, que comprenden administrar al animal una composición de la invención. En la invención, particularmente la respuesta inmune es una respuesta inmune protectora. La invención comprende un procedimiento para preparar una composición inmunológica que comprende añadir Quil A a un virus.
CO11022016A 2008-08-19 2011-02-23 Composicion inmunologica CO6341568A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008904261A AU2008904261A0 (en) 2008-08-19 Immunological Composition
US9209108P 2008-08-27 2008-08-27

Publications (1)

Publication Number Publication Date
CO6341568A2 true CO6341568A2 (es) 2011-11-21

Family

ID=41696586

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11022016A CO6341568A2 (es) 2008-08-19 2011-02-23 Composicion inmunologica

Country Status (17)

Country Link
US (1) US20100047279A1 (es)
EP (1) EP2331126A1 (es)
JP (1) JP2012500282A (es)
KR (1) KR101320141B1 (es)
CN (1) CN102186502B (es)
AR (1) AR076437A1 (es)
AU (1) AU2009282581B2 (es)
BR (1) BRPI0917290A8 (es)
CA (1) CA2734654C (es)
CO (1) CO6341568A2 (es)
HK (1) HK1157182A1 (es)
MX (1) MX2011001910A (es)
RU (1) RU2506094C2 (es)
TW (1) TW201010719A (es)
UA (1) UA101385C2 (es)
WO (1) WO2010022135A1 (es)
ZA (1) ZA201102082B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
AU2011224188B2 (en) * 2010-03-12 2015-01-22 Boehringer Ingelheim Animal Health USA Inc. Bluetongue virus recombinant vaccines and uses thereof
WO2012154739A1 (en) * 2011-05-09 2012-11-15 Uwm Research Foundation, Inc. The use of cyclodextrins in diets, water or vaccine adjuvants to boost the immune system of fish
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
EP3057613A1 (en) 2013-10-17 2016-08-24 Zoetis Services LLC Methods and compositions for treatment of s. equi infection
MY181854A (en) * 2014-05-23 2021-01-11 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
DE69929444T2 (de) * 1998-08-10 2006-09-28 Antigenics Inc., Woburn Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
WO2003009812A2 (en) * 2001-07-25 2003-02-06 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
CN1909925B (zh) * 2004-02-20 2010-10-13 中国农业大学 一种免疫佐剂
EP1765385A4 (en) * 2004-06-16 2008-08-27 Smart Drug Systems Inc IMPORTS COMPOSITION WITH DELAYED RELEASE
RU2288007C2 (ru) * 2005-02-17 2006-11-27 ГНУ ВНИИ ветеринарной вирусологии и микробиологии Способ изготовления ассоциированной инактивированной культуральной вакцины против инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота

Also Published As

Publication number Publication date
KR101320141B1 (ko) 2013-11-13
RU2011105863A (ru) 2012-09-27
AU2009282581B2 (en) 2013-12-19
WO2010022135A1 (en) 2010-02-25
CA2734654C (en) 2015-02-10
CA2734654A1 (en) 2010-02-25
ZA201102082B (en) 2011-11-30
EP2331126A1 (en) 2011-06-15
KR20110044791A (ko) 2011-04-29
JP2012500282A (ja) 2012-01-05
TW201010719A (en) 2010-03-16
CN102186502A (zh) 2011-09-14
BRPI0917290A2 (pt) 2015-11-10
RU2506094C2 (ru) 2014-02-10
MX2011001910A (es) 2011-06-20
HK1157182A1 (en) 2012-06-29
UA101385C2 (ru) 2013-03-25
AU2009282581A1 (en) 2010-02-25
BRPI0917290A8 (pt) 2016-11-01
AR076437A1 (es) 2011-06-15
US20100047279A1 (en) 2010-02-25
CN102186502B (zh) 2014-07-16

Similar Documents

Publication Publication Date Title
CO6341568A2 (es) Composicion inmunologica
MY150706A (en) Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
AR082686A1 (es) Adyuvantes de vacuna que direccionan a los adyuvantes de anticuerpos directamente hacia las celulas presentadoras de antigenos
CU23759A3 (es) Composiciones inmunogénicas
BRPI0510430A (pt) composições e métodos para vacinação mucosal
CL2006000880A1 (es) Composicion inmunogena para causar una respuesta inmunologica contra una especie helicobacter y circovirus porcino que comprende antigenos de dichos patogenos; metodo para inducir una respuesta inmunologica contra dichos patogenos; kit para preparar la composicion inmunogena.
BRPI0715396B8 (pt) método de produção de uma composição para vacina
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
BRPI1013780B8 (pt) Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
BR112012004698A2 (pt) métodos de redução de atividade virucida em composições de pcv-2 e composições de pcv-2 com uma imonugenicidade aprimorada.
CO5700790A2 (es) Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina
CO6150189A2 (es) Vacunas para malaria
CO6260103A2 (es) Composiciones que comprenden antigenos neumococidos
CL2011000382A1 (es) Uso de una composicion inmunogenica que comprende una cantidad eficaz de un virus de sindrome disgenesico y respiratorio porcino (prrs) tipo ii para disminuir la incidencia, gravedad o prevenir los efectos de una enfermedad con fiebre alta de prrs.
CO6331297A2 (es) Composiciones adyuvantes novedosas
AR052498A1 (es) Vacuna
SG158154A1 (en) Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
CL2011001993A1 (es) Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio; metodo de produccion; y su uso para prevenir, mejorar o tratar una enfermedad productiva por el virus del dengue en un sujeto.
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
BR112013000394B8 (pt) Composição imunogênica, uso da mesma e método para preparar a referida composição
MX2009006178A (es) Vacuna contra salmonela.
CR8638A (es) Vacuna agalactiae estreptococos
BR112015005056A2 (pt) vacinas de combinação com sorogrupo b meningococcus e d/t/p
BRPI0920982A8 (pt) Vírus da diarreia viral bovina com uma proteína erns.
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus

Legal Events

Date Code Title Description
FC Application refused